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ABSTRACT
Objective: The present study is to formulate and evaluate the ketoprofen transdermal matrix patch which containing different polymer components.
Methods: The transdermal matrix patch of ketoprofen was formulated using four formulas using polyethylene glycol 400, polyvinylpyrrolidone K-30, 
and ethyl cellulose as the polymer. The transdermal matrix patch was evaluated for various physicochemical characteristics and drug contain. The 
interaction between the polymers and ketoprofen was characterized using Fourier-transform infrared.
Results: Surfactants, cosurfactants, and oils used for the nanoemulsion formula are tween 80, ethanol, and isopropyl myristate (IPM). Formulation of 
ketoconazole nanoemulsion with comparison of tween 80 concentration with ethanol (smix) 4:1 and smix with oil 9:1 was found that the formulae 
F1, F2, F3, F4, F5, F6, and F7 are unstable and formulae F8, F9, F10, F11, and F12 are stable at the period of manufacture. The best physical stability 
tests from F8, F9, F10, F11, and F12 are F10.
Conclusions: Optimization of ketoconazole nanoemulsion formula was obtained at tween 80 36% concentration, 9% ethanol, and IPM 5%
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INTRODUCTION
Topical drug delivery methods have advantages over other delivery 
methods, one of which is to avoid the metabolism of the first pass effect 
on the liver [1]. Physical-chemical characteristic of drugs and excipients 
are taken into consideration in designing formulas to produce a product 
that is stable, efficacious, attractive, easy to formulate, and safe. These 
characteristics affect several factors: Particle size distribution, drug 
dissolution rate, bioavailability, uniformity of content, taste, texture, 
color, and stability. The particle size and solubility of the drug have 
an effect on the formulation because the drugs entering the blood 
circulation must be in solution form to produce the desired effect 
(Fig. 1).
Ketoconazole is included in Class II of Biopharmaceutical Classification 
System means, including a class of low solubility and high permeability, 
the increased solubility of this drug is of concern to pharmaceutical 
researchers [2]. The absorption of ketoconazole orally is not maximal due 
to the solubility and the side effects it causes; to overcome the deficiencies 
of this conventional system a new drug delivery system is required. Topical 
ketoconazole available on the market today, such as cream has side effects 
such as rash, itching, irritation, pain, and redness; therefore, to overcome 
this problem requires a new drug delivery system such as nanoemulsion. 
Nanoemulsion has been widely used as a vehicle in topical medicine and 
is an alternative to insoluble, topical, or oral drugs.
Nanoemulsions are thermodynamically stable dispersions of two 
immiscible liquids (oil and water) which is stabilized using a surfactant 
and cosurfactant molecule. They may be either transparent or 
translucent and have a droplet size of 5–200 nm [3]. They are well-
tolerated orally, on the skin and mucous membrane when used to deliver 
topically active drugs. Nowadays, increasing drug loading, enhancing 
drug solubility, and bioavailability are the most important advantages 
of encouraging the usage of nanoemulsion as drug delivery carriers. 
A topical nanoemulsion is a form of delivery for a drug that is difficult to 
dissolve and has side effects when administered orally by increasing the 
penetration of the drug through the skin [4]. Nanoemulsions comprise 
safe surfactants with or without other emulsifiers to improve stability, 
oil (natural/synthetic/semi-synthetic), and cosurfactant [4].
The method of nanoemulsion formulation is divided into two methods 
that use high energy and low energy. High energy formulations require 
tools such as high-pressure homogenizers, Microfluidizers, and 
sonicators, and low energy formulation methods dependent on the 
solubility of the active substance so that it is more efficient to make a 
small droplet nanoemulsion. Nanoemulsions produced with low energy 
methods depend on the spontaneous formation of emulsions based on 
the phase behavior of certain surfactant, oil, and water systems. There 
is interest in using lower energy techniques in the emulsion formation 
process due to the economic benefits, and increasing amounts of 
research have been conducted to investigate the utility of different low-
energy approaches. Self-emulsifying systems offer a strategy for dealing 
with the low bioavailability of compounds (drugs and oils) that are not 
easily dissolved in water [5].
A low energy emulsification or spontaneous emulsification method 
used by the laboratory scale to achieve small droplet size using simple 
instruments [6]. The advantage of the low energy method is that it 
can use simple equipment such as a magnetic stirrer, which includes 
low energy manufacturing methods are phase inversion temperature 
and phase inverse composition. The nanoemulsion method of PIC 




Ketoprofen was purchased from PT. Dexa Medica (Indonesia). 
Polyethylene glycol (PEG) 400 (Merck), polyvinylpyrrolidone (PVP) 
K-30 (Merck), ethyl cellulose (EC) (Merck), Chloroform (Merck), 
Methanol (Merck), and Menthol (Merck) were used. All the ingredients 
were of analytical grade.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i11.27282
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Formulation of ketoprofen matrix transdermal patch
Matrix transdermal patch of ketoprofen was prepared using the solvent 
evaporation method. The polymeric solvent was prepared by dissolving 
all the polymer (PEG, PVP, and EC), menthol and active chemical 
compound (ketoprofen) in the blend of chloroform and methanol 
(1:1). The polymeric mixtures then poured into a mold and kept at 
room temperature until dry. The formulas design of ketoprofen matrix 
transdermal patch is shown in Table 1.
Physicochemical compatibility of drug and polymers
The compatibility of the drug and polymers was studied using a 
Shimazu Fourier-transform infrared (FTIR) spectrophotometer 
in range 4000–400/cm. The FTIR spectra of drug and polymers 
in the mixture are compared for the presence or absence of 
incompatibility [11].
Evaluation of ketoprofen matrix transdermal patch
Visual
The visual of matrix transdermal patch parameters is color, odor, 
texture, and film flexibility [12].
Weight variation
The weight variation five patches were weighed on an electronic 
balance, and the average of weight was taken with SD [12].
Film thickness
The thickness of films was measured by micrometer screw at five 
different sites, and average of five readings was taken with SD [12].
Moisture uptake
The percentage of moisture uptake was calculated as the difference 








The folding endurance was measured manually for prepared films. 
A strip of film was folded at the same place till it broke. The number of 
time the film can be folded at the same place without breaking was the 
folding endurance value [13].
Drug content
A 0.1 mm thickness of the film was cut and put it into a 100 ml 
phosphate buffer (pH 7.4) and ultrasonicated for 15 min with a stirrer. 
After filtration, the drug was estimated spectrometrically at wavelength 
of 260 nm and determined the drug content compared using the 
calibration curve of ketoprofen [12].
RESULTS AND DISCUSSION
Physicochemical compatibility study
All the characteristic peaks of the pure drug ketoprofen were retained in drug 
and polymers physical mixtures, which indicate that the drug and polymers 
are compatible. The result of the FTIR studies was shown in Figs. 2 and 3.
Evaluation of ketoprofen matrix transdermal patch
The results of evaluation of various visual and physicochemical 
parameters of the ketoprofen matrix transdermal patch were presented 
Fig. 1. The structure of ketoprofen
Table 1: Formula design of ketoprofen matrix transdermal patch
Composition (in mg) Formula
F1 F2 F3 F4
PEG 85 170 42.5 42.5
PVP 85 42.5 170 42.5
EC 85 42.5 42.5 170
Menthol 25 25 25 25
Ketoprofen 20 20 20 20
PEG: Polyethylene glycol, PVP: Polyvinylpyrrolidone, EC: Ethylcellulose
Fig. 2. The Fourier-transform infrared spectra of drug and 
polymers
Fig. 3. The Fourier-transform infrared spectra of drug and 
polymers in a physical mixture of four formula
Table 2: Visual evaluation of ketoprofen matrix transdermal 
patch
Formula Color Odor Texture Flexibility
F1 White Odorless Flat surface Not flexible
F2 Transparent Odorless Flat surface Flexible
F3 Transparent Odorless Flat surface Flexible
F4 White Odorless Flat surface Not flexible
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in Tables 2 and 3. The calibration curve of ketoprofen was presented 
in Fig. 4. All the physicochemical parameters meet the applicable 
requirements. The drug content was also studied for all formulations 
indicating that the method used to formulated this ketoprofen matrix 
transdermal patch was suited or not.
F3 showed the heaviest weight compared to other formulas. In F3, it 
showed that the PVP is the main factor that affects the weight because 
PVP is a hygroscopic agent. F4 showed the thickest thickness layer 
compared to other formulas. It can happen due to the ES content. 
This is because the ES polymer if excessively given will form a thick 
and uneven fiber that affects the weight of the patch [14-16]. The 
calibration curve of ketoprofen in 260 nm wavelength showed a 
good coefficient correlation (0.9998). The coefficient correlation can 
be accepted which the value of the coefficient correlation should not 
smaller than 0.995 [17,18]. Moisture uptake and drug content result, 
all the formula showed a good percentage in the range that can be 
accepted. Folding endurance result showed that all formula can be 
accepted [19,20].
CONCLUSIONS
In the present study, various formulations of the ketoprofen matrix 
transdermal patch were prepared. On the evaluations and FTIR study, 
all the formulas showed good uniformity and acceptable. Hence, it can 
be concluded that these three type of polymers (PEG, PVP, and ES) can 
be used as a polymer base for formulating ketoprofen transdermal drug 
delivery system.
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Table 3: Physicochemical evaluation and drug content
Formula Physicochemical parameter
Weight (mg) Thickness (mm) Moisture uptake (%) Folding endurance Drug content (%)
F1 272±5.89 0.977±0.00057 1.1±0.015 <200 97.68
F2 2.82±1.52 0.968±0.00057 2.57±0.214 <200 95.26
F3 283±2.51 0.961±0.00057 2.83±0.050 <200 97.98
F4 265±3 0.989±0.0066 1.68±0.158 <200 97.50
Fig. 4. The calibration curve of ketoprofen
